Adam Knight is a venture capitalist and scientist, currently serving as Co-founder and Partner at Neuro. VC. He founded Neuron23, a clinical-stage biotech company, raising over $300M and leading it for over five years. He holds a PhD from the University of Cambridge and began his research career at The University of Alabama.
Adam is passionate about advancing treatments for neurodegenerative diseases, a journey that started nearly two decades ago. He is deeply supportive of his family, particularly celebrating the entrepreneurial success of his twin brother, Robby Knight. Adam draws inspiration from his personal experiences growing up in Alabama.
He founded Neuron23 just two years after completing his PhD, successfully building it into a clinical-stage company.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.